US4844732A
(en)
|
1985-10-24 |
1989-07-04 |
Daicel Chemical Industries Ltd. |
Pyridine-3-carboxamide derivatives
|
JPH075554B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
5−ブロモピリドン−3−カルボキサミド化合物の製法
|
JPH075555B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
ピリドン−3−カルボキサミドの製法
|
AU6062590A
(en)
|
1989-07-07 |
1991-02-06 |
Schering Corporation |
Pharmaceutically active compounds
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
FR2665440B1
(fr)
|
1990-07-31 |
1994-02-04 |
Lipha |
Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
|
JPH05107574A
(ja)
|
1991-03-12 |
1993-04-30 |
Mitsui Petrochem Ind Ltd |
有機非線形光学材料
|
PT100639A
(pt)
|
1991-06-27 |
1993-09-30 |
Univ Virginia Commonwealth |
Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina
|
US5356897A
(en)
|
1991-09-09 |
1994-10-18 |
Fujisawa Pharmaceutical Co., Ltd. |
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
|
IT1254134B
(it)
|
1992-01-16 |
1995-09-08 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso chimicamente modificati.
|
EP0558245A1
(en)
|
1992-02-25 |
1993-09-01 |
RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY |
Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
|
IT1254469B
(it)
|
1992-02-25 |
1995-09-25 |
Recordati Chem Pharm |
Derivati benzopiranici e benzotiopiranici
|
EP0664792B1
(en)
|
1992-10-14 |
2000-01-05 |
Merck & Co. Inc. |
Fibrinogen receptor antagonists
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB2300856A
(en)
|
1995-05-16 |
1996-11-20 |
Pfizer Ltd |
Beta-lactam preparation
|
JP3964478B2
(ja)
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
WO1997014419A1
(en)
|
1995-10-20 |
1997-04-24 |
Flora Inc. |
Transdermal delivery of alpha adrenoceptor blocking agents
|
JP2000504014A
(ja)
|
1996-01-30 |
2000-04-04 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質転移酵素の阻害剤
|
US5968965A
(en)
|
1996-01-30 |
1999-10-19 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
FR2746309B1
(fr)
|
1996-03-22 |
1998-04-17 |
Oreal |
Composition de teinture des fibres keratiniques contenant des pyrazolopyrimidineoxo ; leur utilisation pour la teinture comme coupleurs, procedes de teinture
|
PT1027359E
(pt)
|
1996-10-16 |
2003-09-30 |
Ribapharm Inc |
L-nucleosideos monociclicos analogos e suas utilizacoes
|
ATE258050T1
(de)
|
1996-10-31 |
2004-02-15 |
Harbor Branch Oceanographic |
Verwendung neurogen-entzuendungshemmender verbindungen und zusammensetzungen
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
US5942508A
(en)
|
1997-02-04 |
1999-08-24 |
Senju Pharmaceutical Co., Ltd. |
Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
|
EP1025857A4
(en)
|
1997-10-22 |
2003-11-12 |
Eisai Co Ltd |
RETINOIC ACID AGONISTS, PREVENTIVE AND THERAPEUTIC AGENTS FOR NEPHRITES
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
BR9914207A
(pt)
|
1998-09-30 |
2001-07-03 |
Procter & Gamble |
Ceto-amidas 2-substituìdas
|
WO2000025789A1
(en)
|
1998-10-29 |
2000-05-11 |
Merck & Co., Inc. |
A method of treating endometriosis
|
SK15522001A3
(sk)
|
1999-04-28 |
2002-06-04 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselín s tromi arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
|
WO2001012183A1
(en)
|
1999-08-16 |
2001-02-22 |
Merck & Co., Inc. |
Heterocycle amides as cell adhesion inhibitors
|
WO2001019798A2
(en)
|
1999-09-17 |
2001-03-22 |
Cor Therapeutics Inc. |
INHIBITORS OF FACTOR Xa
|
MX226123B
(es)
|
1999-09-17 |
2005-02-07 |
Millennium Pharm Inc |
Benzamidas e inhibidores del factor xa relacionadas.
|
IL148577A0
(en)
|
1999-10-29 |
2002-09-12 |
Pfizer Prod Inc |
Hygromycin derivatives
|
IL149177A0
(en)
|
1999-11-05 |
2002-11-10 |
Sod Conseils Rech Applic |
Novel heterocyclic compounds and their use as medicines
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
WO2001064643A2
(en)
|
2000-02-29 |
2001-09-07 |
Cor Therapeutics, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
EP1267874A2
(en)
|
2000-03-09 |
2003-01-02 |
Aventis Pharma Deutschland GmbH |
Therapeutic uses of ppar mediators
|
EP1303757B1
(en)
|
2000-07-10 |
2006-10-11 |
Vertex Pharmaceuticals (San Diego) LLC |
Ion channel assay methods
|
WO2002020492A1
(en)
|
2000-09-06 |
2002-03-14 |
Neurogen Corporation |
Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
|
EP1404680A2
(en)
|
2000-10-24 |
2004-04-07 |
Glaxo Group Limited |
Process for preparing intermediates of hiv protease inhibitors
|
MXPA03003829A
(es)
|
2000-11-04 |
2003-07-28 |
Aventis Pharma Ltd |
Acidos alcanoicos substituidos.
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
CN100509794C
(zh)
|
2001-01-16 |
2009-07-08 |
阿斯特拉曾尼卡有限公司 |
治疗性杂环化合物
|
BR0207996A
(pt)
|
2001-03-05 |
2004-03-02 |
Du Pont |
Composto, método de controle de pragas invertebradas e composição para controle das mesmas
|
MXPA03009000A
(es)
|
2001-04-13 |
2004-02-12 |
Boehringer Ingelheim Pharma |
Compuestos benzo-fusionados 1,4-disustituidos.
|
JP2003034671A
(ja)
|
2001-05-17 |
2003-02-07 |
Nippon Nohyaku Co Ltd |
ベンズアミド誘導体及び農園芸用薬剤並びにその使用方法
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20050080112A1
(en)
|
2001-06-22 |
2005-04-14 |
Madsen Lars Siim |
Compounds for use in disorders associated with mast cell or basophil acitvity
|
BRPI0212726B8
(pt)
|
2001-09-21 |
2021-05-25 |
Bristol Myers Squibb Co |
compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
CA2465597A1
(en)
|
2001-11-14 |
2003-06-12 |
Ben Zion Dolitzky |
Amorphous and crystalline forms of losartan potassium and process for their preparation
|
JP2005510564A
(ja)
|
2001-11-28 |
2005-04-21 |
藤沢薬品工業株式会社 |
アポリポタンパク質b阻害剤としての複素環式アミド化合物
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
WO2003062221A1
(en)
|
2002-01-22 |
2003-07-31 |
E.I. Du Pont De Nemours And Company |
Diamide invertebrate pest control agents
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
JP4164031B2
(ja)
|
2002-02-14 |
2008-10-08 |
ファルマシア コーポレーション |
P38mapキナーゼのモジュレータとしての置換されたピリジノン
|
ATE375350T1
(de)
|
2002-02-21 |
2007-10-15 |
Lilly Co Eli |
Modulatoren von peroxisome proliferator- aktivierten rezeptoren
|
EP1485395A4
(en)
|
2002-02-28 |
2011-04-13 |
Biota Scient Management |
NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF
|
CA2504044A1
(en)
|
2002-11-01 |
2004-05-21 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
US7189716B2
(en)
|
2003-01-03 |
2007-03-13 |
Bristol-Myers Squibb Company |
Tyrosine kinase inhibitors
|
CA2512582C
(en)
|
2003-01-08 |
2014-07-08 |
University Of Washington |
Antibacterial agents
|
US7122557B2
(en)
|
2003-03-18 |
2006-10-17 |
Bristol-Myers Squibb Company |
Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
|
WO2004090154A2
(en)
|
2003-04-01 |
2004-10-21 |
Activx Biosciences, Inc. |
Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
PT1635824E
(pt)
|
2003-06-03 |
2009-11-24 |
Novartis Ag |
Inibidores de p-38 à base de heterociclos de 5 membros
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
CA2539227A1
(en)
|
2003-08-08 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
BRPI0413682A
(pt)
|
2003-08-21 |
2006-10-24 |
Univ Griffith |
compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
|
WO2005019237A1
(en)
|
2003-08-21 |
2005-03-03 |
Griffith University |
Novel sulfenamides
|
CN1863813B
(zh)
|
2003-08-27 |
2011-03-30 |
生物区科学管理控股有限公司 |
作为治疗剂的三环核苷或核苷酸
|
US7932272B2
(en)
|
2003-09-30 |
2011-04-26 |
Eisai R&D Management Co., Ltd. |
Antifungal agent containing heterocyclic compound
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
JP4526801B2
(ja)
|
2003-11-13 |
2010-08-18 |
新日鐵化学株式会社 |
複素環化合物の製造方法
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
EP1689407A1
(en)
|
2003-11-25 |
2006-08-16 |
Pfizer Products Inc. |
Method of treatment of atherosclerosis
|
CA2574600C
(en)
|
2004-07-23 |
2010-08-31 |
Pfizer Inc. |
Pyridine derivatives
|
WO2006017896A1
(en)
|
2004-08-16 |
2006-02-23 |
The University Of Queensland |
Metabolism-modulating agents and uses therefor
|
AU2005282761B2
(en)
|
2004-09-02 |
2012-02-02 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
WO2006094347A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
WO2006113615A2
(en)
|
2005-04-15 |
2006-10-26 |
Sloan-Kettering Institute For Cancer Research |
Anti-microbial agents and uses thereof
|
EP1879858A2
(en)
|
2005-05-09 |
2008-01-23 |
Vertex Pharmaceuticals, Inc. |
Processes for preparing biaryl ureas and analogs thereof
|
WO2006124780A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
EP1891039A1
(en)
|
2005-05-20 |
2008-02-27 |
Vertex Pharmaceuticals Incorporated |
Quinoline derivatives useful as modulators of ion channels
|
US7880008B2
(en)
|
2005-05-31 |
2011-02-01 |
Vertex Pharmaceuticals Incorporated |
Heterocycles useful as modulators of ion channels
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
US20070203224A1
(en)
|
2006-01-09 |
2007-08-30 |
University Of Southern California |
Small-molecules for treating cancer and abnormal cell proliferation disorders
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
US9155792B2
(en)
|
2006-02-13 |
2015-10-13 |
Trustees Of Boston University |
RecA inhibitors with antibiotic activity, compositions and methods of use
|
TW200808723A
(en)
|
2006-03-13 |
2008-02-16 |
Univ California |
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
|
US7480400B2
(en)
|
2006-03-16 |
2009-01-20 |
Siemens Medical Solutions Usa, Inc. |
Detection of fiber pathways
|
KR20080109918A
(ko)
|
2006-04-11 |
2008-12-17 |
버텍스 파마슈티칼스 인코포레이티드 |
전압 개폐 나트륨 채널의 억제제로서 유용한 조성물
|
WO2007146712A2
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
EP2035395A2
(en)
|
2006-06-27 |
2009-03-18 |
Glenmark Pharmaceuticals S.A. |
Novel processes for the preparation of dpp iv inhibitors
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
EP1882475A1
(en)
|
2006-07-26 |
2008-01-30 |
Novartis AG |
Method of treating disorders mediated by the fibroblast growth factor receptor
|
JP5274460B2
(ja)
|
2006-08-08 |
2013-08-28 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
E1活性化酵素のインヒビターとして有用なヘテロアリール化合物
|
WO2008018129A1
(fr)
|
2006-08-09 |
2008-02-14 |
Shinichiro Isobe |
Procédé de détection de protéine et colorant fluorescent utilisé à cet effet
|
CA2663147A1
(en)
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
|
EP2061468A4
(en)
|
2006-09-11 |
2011-05-04 |
Curis Inc |
TYROSINE KINASE INHIBITORS CONTAINING ZINC BINDING CHARACTERISTIC GROUP
|
JP5460324B2
(ja)
|
2006-10-12 |
2014-04-02 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
治療剤としてのスピロ−オキシインドール化合物の使用
|
AU2007327621A1
(en)
|
2006-11-27 |
2008-06-05 |
Novartis Ag |
Substituted dihydroimidazoles and their use in the treatment of tumors
|
AU2007333377B2
(en)
|
2006-12-08 |
2014-01-16 |
Millennium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor
|
TWI399380B
(zh)
|
2006-12-20 |
2013-06-21 |
Abbott Lab |
抗病毒化合物
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2008094507A2
(en)
|
2007-01-26 |
2008-08-07 |
Cellicon Biotechnologies, Inc. |
Novel fusion compounds
|
JP2010522163A
(ja)
|
2007-03-20 |
2010-07-01 |
キュリス,インコーポレイテッド |
亜鉛結合部位を含むRafキナーゼインヒビター
|
WO2008115262A2
(en)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Hsp90 inhibitors containing a zinc binding moiety
|
CA2684105C
(en)
|
2007-05-03 |
2011-09-06 |
Pfizer Limited |
Pyridine derivatives
|
WO2008156783A2
(en)
|
2007-06-18 |
2008-12-24 |
University Of Louisville Research Foundation, Inc. |
Family of pfkfb3 inhibitors with anti-neoplastic activities
|
CN101687815A
(zh)
|
2007-06-26 |
2010-03-31 |
塞诺菲-安万特股份有限公司 |
苯并咪唑和氮杂苯并咪唑的区域选择性铜催化合成
|
ES2551095T3
(es)
|
2007-07-19 |
2015-11-16 |
Lundbeck, H., A/S |
Amidas heterocíclicas de 5 miembros y compuestos relacionados
|
JP4834699B2
(ja)
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
JP4846769B2
(ja)
|
2007-07-30 |
2011-12-28 |
田辺三菱製薬株式会社 |
医薬組成物
|
FR2919869B1
(fr)
|
2007-08-09 |
2009-09-25 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2009036066A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Vegfr inhibitors containing a zinc binding moiety
|
WO2009036051A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Bcl-2 inhibitors containing a zinc binding moiety
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
MX2010003449A
(es)
|
2007-09-26 |
2010-04-27 |
Astellas Pharma Inc |
Derivado de quinolona.
|
BRPI0818501A2
(pt)
|
2007-10-08 |
2015-04-22 |
Advinus Therapeutics Private Ltd |
Derivados de acetamida como ativadores de glicoquinase, seu processo e aplicações medicinais
|
US8519137B2
(en)
|
2007-10-11 |
2013-08-27 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
MX2010003865A
(es)
|
2007-10-11 |
2010-06-01 |
Vertex Pharma |
Aril amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
|
US8389734B2
(en)
|
2007-10-11 |
2013-03-05 |
Vertex Pharmaceuticals Incorporated |
Amides useful as inhibitors of voltage-gated sodium channels
|
WO2009069132A2
(en)
|
2007-11-29 |
2009-06-04 |
Ramot At Tel Aviv University Ltd. |
Novel reverse transcriptase inhibitors
|
EP2231671B1
(en)
|
2007-12-13 |
2013-04-24 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
EP2219646A4
(en)
|
2007-12-21 |
2010-12-22 |
Univ Rochester |
METHOD FOR MODIFYING THE LIFETIME OF EUKARYOTIC ORGANISMS
|
US20110046199A1
(en)
|
2008-01-17 |
2011-02-24 |
Purdue Research Foundation |
Small molecule inhibitors of hiv proteases
|
WO2009114470A2
(en)
|
2008-03-10 |
2009-09-17 |
Curis, Inc. |
Tetrahydroindole and tetrahdyroindazole as hsp90 inhibitors containing a zinc binding moiety
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
EP2282742A1
(en)
|
2008-04-09 |
2011-02-16 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
EP3289876B1
(en)
|
2008-06-16 |
2022-07-20 |
University of Tennessee Research Foundation |
Compounds for treatment of cancer
|
JP5758292B2
(ja)
|
2008-07-03 |
2015-08-05 |
サートリス ファーマシューティカルズ, インコーポレイテッド |
サーチュイン調節薬としてのベンズイミダゾールおよび関連する類似体
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
US8541569B2
(en)
|
2008-09-06 |
2013-09-24 |
Chemgenes Corporation |
Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
|
CA2735251C
(en)
|
2008-09-06 |
2017-07-11 |
Chemgenes Corporation |
Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end
|
US8354444B2
(en)
|
2008-09-18 |
2013-01-15 |
Hoffmann-La Roche Inc. |
Substituted pyrrolidine-2-carboxamides
|
PL2340021T3
(pl)
|
2008-09-18 |
2013-04-30 |
Hoffmann La Roche |
Podstawione pirolidyno-2-karboksyamidy
|
WO2010037127A1
(en)
|
2008-09-29 |
2010-04-01 |
Sirtris Pharmaceuticals, Inc. |
Chromenone analogs as sirtuin modulators
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
EP2184273A1
(de)
|
2008-11-05 |
2010-05-12 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
CA2743241A1
(en)
|
2008-11-27 |
2010-06-03 |
Boehringer Ingelheim International Gmbh |
6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
CA2747279A1
(en)
|
2008-12-10 |
2010-06-17 |
Merck Canada Inc. |
3,4 - substituted piperidine derivatives as renin inhibitors
|
WO2010075282A1
(en)
|
2008-12-22 |
2010-07-01 |
University Of Washington |
Molecular inhibitors of the wnt/beta-catenin pathway
|
WO2010072607A1
(en)
|
2008-12-23 |
2010-07-01 |
F. Hoffmann-La Roche Ag |
Dihydropyridone amides as p2x7 modulators
|
LT2380881T
(lt)
|
2008-12-26 |
2017-04-10 |
Sumitomo Dainippon Pharma Co., Ltd. |
Naujas biciklinis heterociklinis junginys
|
KR20100087540A
(ko)
|
2009-01-28 |
2010-08-05 |
삼성전자주식회사 |
잉크젯 기록용 잉크 조성물
|
EP2408449A4
(en)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
METHODS AND COMPOSITIONS FOR TREATING INFECTION WITH A FLAVIVIRIDAE FAMILY VIRUS
|
CN102574786A
(zh)
|
2009-04-02 |
2012-07-11 |
默克雪兰诺有限公司 |
二氢乳清酸脱氢酶抑制剂
|
TWI609855B
(zh)
|
2009-04-28 |
2018-01-01 |
環球展覽公司 |
具有甲基-d3取代之銥錯合物
|
US9174999B2
(en)
|
2009-05-07 |
2015-11-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for studying, imaging, and treating pain
|
CA2763631A1
(en)
|
2009-05-27 |
2010-12-02 |
Abbott Laboratories |
Pyrimidine inhibitors of kinase activity
|
CN102459265A
(zh)
|
2009-05-27 |
2012-05-16 |
雅培制药有限公司 |
激酶活性的嘧啶抑制剂
|
CN105254557A
(zh)
|
2009-05-29 |
2016-01-20 |
拉夸里亚创药株式会社 |
作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
US8629149B2
(en)
|
2009-09-04 |
2014-01-14 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
EP2477625A4
(en)
|
2009-09-14 |
2012-10-24 |
Phusis Therapeutics Inc |
PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS COMPRISING PLECKSTRINE HOMOLOGY DOMAIN INHIBITORS AND METHODS OF USE
|
WO2011037731A1
(en)
|
2009-09-25 |
2011-03-31 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
AU2010306647B9
(en)
|
2009-10-16 |
2016-11-17 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
US11084811B2
(en)
|
2010-03-01 |
2021-08-10 |
Oncternal Therapeutics, Inc. |
Compounds for treatment of cancer
|
RU2581367C2
(ru)
|
2010-03-01 |
2016-04-20 |
Джи Ти Икс, ИНК. |
Соединения для лечения рака
|
WO2011140425A1
(en)
|
2010-05-06 |
2011-11-10 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
JP2013526514A
(ja)
|
2010-05-10 |
2013-06-24 |
ラディカル・セラピューティックス・インコーポレイテッド |
リポ酸およびニトロキシド誘導体およびその使用
|
WO2011151619A1
(en)
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile associated disease
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
US9290485B2
(en)
|
2010-08-04 |
2016-03-22 |
Novartis Ag |
N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
|
WO2012020725A1
(ja)
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
Npy y5受容体拮抗作用を有するヘテロ環誘導体
|
CA2813437A1
(en)
|
2010-10-08 |
2012-04-12 |
Abbvie Inc. |
Furo[3,2-d]pyrimidine compounds
|
GB201017315D0
(en)
|
2010-10-13 |
2010-11-24 |
Antoxis Ltd |
Compound
|
WO2012052540A1
(en)
|
2010-10-21 |
2012-04-26 |
Universitaet Des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
FI20106119A0
(fi)
|
2010-10-27 |
2010-10-27 |
Sirtuin Valley Oy |
Energia-aineenvaihduntaan vaikuttava koostumus
|
GB201020076D0
(en)
|
2010-11-26 |
2011-01-12 |
Liverpool School Tropical Medicine |
Antimalarial compounds
|
DK2646436T3
(en)
|
2010-11-29 |
2015-06-29 |
Pfizer |
monobactams
|
ES2650744T3
(es)
|
2010-12-14 |
2018-01-22 |
Electrophoretics Limited |
Inhibidores de la caseína quinasa 1 delta (CK1delta)
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
WO2012097330A2
(en)
|
2011-01-14 |
2012-07-19 |
University Of Washington |
Compositions and methods for treating degenerative muscle conditions
|
AR085893A1
(es)
|
2011-02-02 |
2013-11-06 |
Vertex Pharma |
Pirrolopirazina-amidas de piperidina espirociclica como moduladores de los canales ionicos
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
JP2012167027A
(ja)
|
2011-02-10 |
2012-09-06 |
Shionogi & Co Ltd |
Npyy5受容体拮抗作用を有する縮合ヘテロ環誘導体
|
CA2827311A1
(en)
|
2011-02-18 |
2012-08-23 |
Vertex Pharmaceuticals Incorporated |
Chroman-spirocyclic piperidine amides as modulators of ion channels
|
WO2012116440A1
(en)
|
2011-03-03 |
2012-09-07 |
Zalicus Pharmaceuticals Ltd. |
Benzimidazole inhibitors of the sodium channel
|
EP2686325B1
(en)
|
2011-03-14 |
2016-12-14 |
Vertex Pharmaceuticals Incorporated |
Morpholine-spirocyclic piperidine amides as modulators of ion channels
|
MX2013010576A
(es)
|
2011-03-15 |
2014-03-12 |
Abbvie Inc |
Moduladores de receptores de hormonas nucleares.
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
JP5866100B2
(ja)
|
2011-04-13 |
2016-02-17 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
JP2014513699A
(ja)
|
2011-05-11 |
2014-06-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
スピロ−オキシインドールmdm2アンタゴニスト
|
EP2713722B1
(en)
|
2011-05-31 |
2017-03-15 |
Receptos, LLC |
Novel glp-1 receptor stabilizers and modulators
|
WO2012170371A1
(en)
|
2011-06-10 |
2012-12-13 |
N30 Pharmaceuticals, Llc |
Compounds as s-nitrosoglutathione reductase inhibitors
|
WO2012178123A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013022740A2
(en)
|
2011-08-05 |
2013-02-14 |
Corning Incorporated |
Gpr35 ligands and the uses thereof
|
MX346095B
(es)
|
2011-09-12 |
2017-03-07 |
Merck Patent Gmbh |
Nuevas imidazol-aminas como moduladores de la actividad de cinasas.
|
US20140241990A1
(en)
|
2011-09-30 |
2014-08-28 |
Tufts University |
Methods of using adenosine a1 receptor activation for treating depression
|
PE20141682A1
(es)
|
2011-10-26 |
2014-11-14 |
Pfizer Ltd |
Derivados de (4-fenilimidazol-2-il) etilamina utiles como moduladores de canal de sodio
|
EP2788332A1
(en)
|
2011-12-07 |
2014-10-15 |
Amgen, Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
CN103159738B
(zh)
|
2011-12-19 |
2016-09-07 |
上海泓博智源医药股份有限公司 |
炔基桥连的杂芳香化合物及其应用
|
US9403839B2
(en)
|
2012-01-16 |
2016-08-02 |
Vertex Pharmaceuticals Incorporated |
Pyran-spirocyclic piperidine amides as modulators of ion channels
|
FR2985916B1
(fr)
|
2012-01-25 |
2015-12-04 |
Univ Bordeaux Segalen |
Decontamination par hydrogels d'echantillons aqueux contenant des nanoparticules
|
WO2013114250A1
(en)
|
2012-02-03 |
2013-08-08 |
Pfizer Inc. |
Benziimidazole and imidazopyridine derivatives as sodium channel modulators
|
CN104395335A
(zh)
|
2012-02-08 |
2015-03-04 |
努艾利克斯德国股份有限公司 |
用于抗体和Fc-融合蛋白亲和色谱IV纯化的配体
|
CN112029513B
(zh)
|
2012-02-22 |
2024-02-23 |
默克专利股份有限公司 |
液晶介质
|
WO2013131018A1
(en)
|
2012-03-02 |
2013-09-06 |
Zalicus Pharmaceuticals Ltd. |
Biaryl inhibitors of the sodium channel
|
EP2822953B9
(en)
|
2012-03-06 |
2017-06-21 |
Pfizer Inc |
Macrocyclic derivatives for the treatment of proliferative diseases
|
JP5798066B2
(ja)
|
2012-03-08 |
2015-10-21 |
富士フイルム株式会社 |
化合物、液晶組成物、高分子材料およびフィルム
|
US9051311B2
(en)
|
2012-03-09 |
2015-06-09 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
JP5804991B2
(ja)
|
2012-03-19 |
2015-11-04 |
富士フイルム株式会社 |
光反射フィルム、自動車用フロントガラス、建材用ガラス
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
JP6067108B2
(ja)
|
2012-05-30 |
2017-01-25 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
置換ピロリジン−2−カルボキサミド
|
JP5867298B2
(ja)
|
2012-06-06 |
2016-02-24 |
Jsr株式会社 |
フォトレジスト組成物及びレジストパターン形成方法
|
WO2013188881A1
(en)
|
2012-06-15 |
2013-12-19 |
President And Fellows Of Harvard College |
Compounds, compositions and methods for treating or preventing neurodegenerative disorders
|
US20140005181A1
(en)
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
WO2014003153A1
(ja)
|
2012-06-28 |
2014-01-03 |
協和発酵キリン株式会社 |
置換アミド化合物
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
US9040498B2
(en)
|
2012-07-06 |
2015-05-26 |
Research Foundation Of The City University Of New York |
1,2,3-Triazolyl purine derivatives
|
JP6256467B2
(ja)
|
2012-07-17 |
2018-01-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロイコトリエン生成を阻害するピラゾール誘導体
|
TW201416362A
(zh)
|
2012-07-19 |
2014-05-01 |
Dainippon Sumitomo Pharma Co |
1-(環烷基羰基)脯胺酸衍生物
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
BR112015001613B1
(pt)
|
2012-07-27 |
2021-02-23 |
Biogen Ma Inc |
compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx, seus usos e composição farmacêutica
|
WO2014020152A1
(en)
|
2012-08-02 |
2014-02-06 |
Graffinity Pharmaceuticals Gmbh |
Ligands for apheresis and immunoabsorption
|
EP2892899B1
(en)
|
2012-09-06 |
2018-03-21 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
US10207989B2
(en)
|
2012-09-20 |
2019-02-19 |
Temple University—Of the Commonwealth System of Higher Education |
Substituted alkyl diaryl derivatives, methods of preparation and uses
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
FR2997851B1
(fr)
|
2012-11-09 |
2014-11-28 |
Oreal |
Composition comprenant un derive dicarbonyle et procede de lissage des cheveux a partir de cette composition
|
US9757379B2
(en)
|
2012-11-14 |
2017-09-12 |
The Board Of Regents Of The University Of Texas System |
Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)
|
CA2891013A1
(en)
|
2012-11-16 |
2014-05-22 |
Abdelghani Abe Achab |
Purine inhibitors of human phosphatidylinositol 3-kinase delta
|
US9884886B2
(en)
|
2012-12-06 |
2018-02-06 |
Merck Sharp & Dohme |
Disulfide masked prodrug compositions and methods
|
WO2014108407A1
(en)
|
2013-01-08 |
2014-07-17 |
Savira Pharmaceuticals Gmbh |
Pyridone derivatives and their use in the treatment, amelioration or prevention of a viral disease
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
WO2014118133A1
(en)
|
2013-01-29 |
2014-08-07 |
Amakem Nv |
Pyridine derivatives as soft rock inhibitors
|
KR102226588B1
(ko)
|
2013-01-31 |
2021-03-11 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 아미드
|
SG11201505952WA
(en)
|
2013-01-31 |
2015-08-28 |
Vertex Pharma |
Quinoline and quinazoline amides as modulators of sodium channels
|
TWI606048B
(zh)
|
2013-01-31 |
2017-11-21 |
帝人製藥股份有限公司 |
唑苯衍生物
|
PE20151781A1
(es)
|
2013-01-31 |
2015-12-02 |
Vertex Pharma |
Piridonamidas como moduladores de canales de sodio
|
US20140357636A1
(en)
|
2013-02-21 |
2014-12-04 |
Wayne Rothbaum |
Treatment of Skeletal-Related Disorders
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
US9357781B2
(en)
|
2013-05-03 |
2016-06-07 |
Inscent, Inc. |
Honeybee repellents and uses thereof
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
US9212182B2
(en)
|
2013-06-12 |
2015-12-15 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
TWI637949B
(zh)
|
2013-06-14 |
2018-10-11 |
塩野義製藥股份有限公司 |
胺基三衍生物及含有其等之醫藥組合物
|
TW201534597A
(zh)
|
2013-06-20 |
2015-09-16 |
Ab Science |
作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物
|
WO2015003991A1
(en)
|
2013-07-12 |
2015-01-15 |
Syngenta Participations Ag |
Novel microbiocides
|
AU2014289663B2
(en)
|
2013-07-12 |
2019-03-07 |
Helmholtz-Zentrum Fur Infektionsforschung Gmbh |
Cystobactamides
|
WO2015003723A1
(en)
|
2013-07-12 |
2015-01-15 |
Københavns Universitet |
Substituted 4-proline derivatives as iglur antagonists
|
CA2918365C
(en)
|
2013-07-19 |
2021-09-07 |
Vertex Pharmaceuticals Incorporated |
Sulfonamides as modulators of sodium channels
|
AU2014295000A1
(en)
|
2013-07-25 |
2016-02-18 |
Fondazione Telethon |
Inhibitors of FAPP2 and uses thereof
|
US9789096B2
(en)
|
2013-09-04 |
2017-10-17 |
Board Of Regents Of The University Of Texas System |
Methods and compositions for selective and targeted cancer therapy
|
SI3043803T1
(sl)
|
2013-09-11 |
2022-09-30 |
Emory University |
Nukleotidne in nukleozidne sestave in njihova uporaba
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
CN105593222B
(zh)
|
2013-10-01 |
2018-02-09 |
葛兰素史密斯克莱知识产权发展有限公司 |
用于亲和色谱法和用于延长治疗剂的半衰期的化合物
|
WO2015051173A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc |
Polynucleotide molecules and uses thereof
|
US9700881B2
(en)
|
2013-10-09 |
2017-07-11 |
Emory University |
Heterocyclic coupling catalysts and methods related thereto
|
MY195078A
(en)
|
2013-12-03 |
2023-01-09 |
Fmc Corp |
Pyrrolidinones As Herbicides
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
KR102435145B1
(ko)
|
2013-12-13 |
2022-08-24 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 피리돈 아미드의 프로드럭
|
EP2918275B1
(en)
|
2013-12-13 |
2016-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
KR20150070027A
(ko)
|
2013-12-16 |
2015-06-24 |
메르크 파텐트 게엠베하 |
액정 매질
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
JP6759100B2
(ja)
|
2013-12-30 |
2020-09-23 |
ライフサイ ファーマシューティカルズ,インク. |
治療用阻害化合物
|
WO2015157559A2
(en)
|
2014-04-09 |
2015-10-15 |
Siteone Therapeutics, Inc. |
10',11'-modified saxitoxins for the treatment of pain
|
WO2015162244A1
(en)
|
2014-04-25 |
2015-10-29 |
Basf Se |
N-acylamidine compounds
|
JP6295992B2
(ja)
|
2014-05-09 |
2018-03-20 |
信越化学工業株式会社 |
単量体の製造方法
|
US9701627B2
(en)
|
2014-06-16 |
2017-07-11 |
University Of Maryland, Baltimore |
LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
|
US20170136132A1
(en)
|
2014-06-19 |
2017-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EP3157573A4
(en)
|
2014-06-19 |
2018-02-21 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US20170175129A1
(en)
|
2014-06-19 |
2017-06-22 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
CN106536529B
(zh)
|
2014-07-01 |
2019-09-27 |
莱姆派克斯制药公司 |
硼酸衍生物及其治疗用途
|
WO2016007837A1
(en)
|
2014-07-11 |
2016-01-14 |
Spero Therapeutics, Inc. |
Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors
|
CN107072985B
(zh)
|
2014-07-16 |
2020-02-07 |
莱福斯希医药公司 |
治疗性抑制化合物
|
EP2977374A1
(en)
|
2014-07-21 |
2016-01-27 |
Université de Strasbourg |
Molecules presenting dual emission properties
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
US10913736B2
(en)
|
2014-08-22 |
2021-02-09 |
University Of Washington |
Specific inhibitors of methionyl-tRNA synthetase
|
JP2017538659A
(ja)
|
2014-09-10 |
2017-12-28 |
エピザイム インコーポレイテッド |
Smyd阻害剤
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
JP2016079098A
(ja)
|
2014-10-10 |
2016-05-16 |
塩野義製薬株式会社 |
セフェム化合物
|
JP2017538676A
(ja)
|
2014-11-05 |
2017-12-28 |
ザ ユニバーシティ オブ カンザス |
ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤
|
RU2727651C2
(ru)
|
2014-12-10 |
2020-07-22 |
Марс, Инкорпорейтед |
Вкусоароматические композиции и пищевые продукты для домашних животных, содержащие их
|
FR3030242B1
(fr)
|
2014-12-18 |
2018-01-26 |
L'oreal |
Emulsion contenant un tensioactif gemine ayant deux groupements amide gras et un filtre uv organique hydrosoluble
|
CN105985330A
(zh)
|
2015-02-04 |
2016-10-05 |
苏州旺山旺水生物医药有限公司 |
一类杂环化合物、其制备方法和用途
|
JP6394430B2
(ja)
|
2015-02-13 |
2018-09-26 |
信越化学工業株式会社 |
化合物、高分子化合物、レジスト材料及びパターン形成方法
|
EA032928B1
(ru)
|
2015-03-02 |
2019-08-30 |
Эмджен Инк. |
Бициклические кетосульфонамидные соединения
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
EP3085360A1
(en)
|
2015-04-20 |
2016-10-26 |
Universite De Bordeaux |
Lipid based nanocarrier compositions loaded with metal nanoparticles and therapeutic agent
|
US11040976B2
(en)
|
2015-04-24 |
2021-06-22 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof
|
WO2016186967A1
(en)
|
2015-05-15 |
2016-11-24 |
Gilead Sciences, Inc. |
Benzimidazole and imadazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase
|
EP3303321A1
(en)
|
2015-06-02 |
2018-04-11 |
E. I. du Pont de Nemours and Company |
Substituted cyclic amides and their use as herbicides
|
WO2016198908A1
(en)
|
2015-06-09 |
2016-12-15 |
Abbvie Inc. |
Ror nuclear receptor modulators
|
BR112018000276A2
(pt)
|
2015-07-06 |
2018-09-04 |
Bayer Cropscience Aktiengesellschaft |
heterociclos contendo nitrogênio como pesticidas
|
KR20180035828A
(ko)
|
2015-07-10 |
2018-04-06 |
아비나스 인코포레이티드 |
단백질 분해의 mdm2계 조절인자 및 관련된 이용 방법
|
CN106518766A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
新型二芳基脲类化合物,其制备方法及其医药用途
|
CN106518767A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
|
WO2017051319A1
(en)
|
2015-09-21 |
2017-03-30 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
CA3000708A1
(en)
|
2015-09-30 |
2017-04-06 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
US10874686B2
(en)
|
2015-10-01 |
2020-12-29 |
Memorial Sloan-Kettering Cancer Center |
Anthranilyl-adenosinemonosulfamate analogs and uses thereof
|
WO2017062751A1
(en)
|
2015-10-08 |
2017-04-13 |
The Regents Of The University Of California |
Compounds and methods for promoting stress resistance
|
US20180305334A1
(en)
|
2015-10-14 |
2018-10-25 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
DK3362461T3
(da)
|
2015-10-16 |
2022-05-09 |
Modernatx Inc |
Mrna-cap-analoger med modificeret phosphatbinding
|
EP3381913B1
(en)
|
2015-11-27 |
2021-03-31 |
Mitsubishi Tanabe Pharma Corporation |
2-(((pyrrolidin-3-yl)carbonyl)amino)-1h-imidazole derivatives as melanocortin receptor 1 (mcr1) agonists for treating rheumatoid arthritis
|
GB201522232D0
(en)
|
2015-12-16 |
2016-01-27 |
Liverpool School Tropical Medicine |
Combination product
|
KR102606339B1
(ko)
|
2016-03-02 |
2023-11-24 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
CN114539284A
(zh)
|
2016-03-16 |
2022-05-27 |
库拉肿瘤学公司 |
经取代的menin-mll抑制剂及使用方法
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
PL3436446T3
(pl)
|
2016-03-31 |
2023-09-11 |
Vertex Pharmaceuticals Incorporated |
Modulatory mukowiscydozowego przezbłonowego regulatora przewodnictwa
|
CN105906591A
(zh)
|
2016-04-22 |
2016-08-31 |
中国药科大学 |
2-氨基-γ-丁内酯类盐酸盐的合成
|
WO2017223260A1
(en)
|
2016-06-23 |
2017-12-28 |
Albert Einstein College Of Medicine, Inc. |
Pu.1 inhibitors
|
CN106220667B
(zh)
|
2016-07-21 |
2018-10-30 |
北京航空航天大学 |
螺环有机硅化合物及其应用
|
WO2018045106A1
(en)
|
2016-08-30 |
2018-03-08 |
Ohio State Innovation Foundation |
Anti-fungal treatment
|
WO2018055235A1
(en)
|
2016-09-21 |
2018-03-29 |
University Of Helsinki |
Isoxazole-amides for treating cardiac diseases
|
PE20191153A1
(es)
|
2016-09-28 |
2019-09-05 |
Blade Therapeutics Inc |
Moduladores de calpainas y usos terapeuticos de los mismos
|
EP3519533B1
(en)
|
2016-09-28 |
2020-12-16 |
Merck Patent GmbH |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
WO2018067636A1
(en)
|
2016-10-04 |
2018-04-12 |
Massachusetts Institute Of Technology |
Compositions and methods for selective carbonylation of heterocyclic compounds
|
CN110099909B
(zh)
|
2016-12-12 |
2021-11-19 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
WO2018138358A1
(en)
|
2017-01-30 |
2018-08-02 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
CN108658974A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种内酰胺类化合物及其制备方法和用途
|
CN108658972A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种取代内酰胺类化合物及其制备方法和用途
|
WO2018183781A1
(en)
|
2017-03-29 |
2018-10-04 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
WO2018183782A1
(en)
|
2017-03-29 |
2018-10-04 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
AU2018243749A1
(en)
|
2017-03-31 |
2019-11-21 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors
|
JP2020100564A
(ja)
|
2017-04-03 |
2020-07-02 |
京都薬品工業株式会社 |
リードスルー誘導剤およびその医薬用途
|
WO2018191146A1
(en)
|
2017-04-10 |
2018-10-18 |
Navitor Pharmaceuticals, Inc. |
Heteroaryl rheb inhibitors and uses thereof
|
CN108689942B
(zh)
|
2017-04-11 |
2023-06-09 |
广东东阳光药业有限公司 |
含氮双环化合物及其制备方法和用途
|
TW201900638A
(zh)
|
2017-04-20 |
2019-01-01 |
加州大學董事會 |
K-ras調節劑
|
CN118021814A
(zh)
|
2017-04-21 |
2024-05-14 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
IL270680B
(en)
|
2017-05-16 |
2022-06-01 |
Vertex Pharma |
Deuterium-converted pyridone amides and their prodrugs as sodium channel modulators
|
CN107033149B
(zh)
|
2017-06-12 |
2020-01-03 |
上海交通大学 |
一种dpp-4酶抑制剂及其制备和应用
|
WO2018237194A1
(en)
|
2017-06-21 |
2018-12-27 |
Wave Life Sciences Ltd. |
COMPOUNDS, COMPOSITIONS AND METHODS OF SYNTHESIS
|
BR112020000553A2
(pt)
|
2017-07-11 |
2020-07-21 |
Vertex Pharmaceuticals Incorporated |
carboxamidas como moduladores de canal de sódio
|
CN109320509B
(zh)
|
2017-07-31 |
2022-02-08 |
轩竹生物科技股份有限公司 |
Fxr受体激动剂
|
CN109384712B
(zh)
|
2017-08-14 |
2021-05-07 |
北京宽厚医药科技有限公司 |
靶向nk1受体拮抗剂及其在化疗所致恶心、呕吐治疗中的应用
|
AU2018319016B2
(en)
|
2017-08-17 |
2023-08-31 |
Ikena Oncology, Inc. |
AHR inhibitors and uses thereof
|
US11795162B2
(en)
|
2017-08-18 |
2023-10-24 |
Saint Louis University |
Modulators of the estrogen-related receptor
|
CN109553608B
(zh)
|
2017-09-26 |
2020-12-08 |
北京大学 |
一类五元六元杂环化合物及其制备方法和治疗肿瘤的用途
|
MA50417A
(fr)
|
2017-10-18 |
2020-08-26 |
Epizyme Inc |
Procédés d'utilisation d'inhibiteurs de l'ehmt2 dans le traitement ou la prévention de troubles du sang
|
CA3079412A1
(en)
|
2017-10-18 |
2019-04-25 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors in immunotherapies
|
US20210177827A1
(en)
|
2017-10-25 |
2021-06-17 |
Children`S Medical Center Corporation |
Papd5 inhibitors and methods of use thereof
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
WO2019094732A1
(en)
|
2017-11-10 |
2019-05-16 |
Academia Sinica |
Inhibitors of cyclic-amp response element-binding protein
|
SG11202004318PA
(en)
|
2017-11-15 |
2020-06-29 |
Metabomed Ltd |
Acss2 inhibitors and methods of use thereof
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
EP3502684A1
(en)
|
2017-12-22 |
2019-06-26 |
Universite De Bordeaux |
Method for metal ion detection in aqueous solutions using nucleolipid compounds
|
WO2019137201A1
(zh)
|
2018-01-09 |
2019-07-18 |
四川科伦博泰生物医药股份有限公司 |
杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
|
MX2020007917A
(es)
|
2018-02-08 |
2020-10-28 |
Enyo Pharma |
Derivados de tiofeno no condensados y sus usos.
|
US20190343817A1
(en)
|
2018-02-12 |
2019-11-14 |
Vertex Pharmaceuticals Incorporated |
Method of treating pain
|
EP3749195B1
(en)
|
2018-04-05 |
2023-10-18 |
St. Jude Medical, Cardiology Division, Inc. |
High density electrode mapping catheter
|
WO2019207081A1
(en)
|
2018-04-27 |
2019-10-31 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
KR20210005160A
(ko)
|
2018-04-27 |
2021-01-13 |
메르크 파텐트 게엠베하 |
중합성 액정 물질 및 중합된 액정 필름
|
WO2019222414A1
(en)
|
2018-05-16 |
2019-11-21 |
Belite Bio, Llc |
Fatty acid analogues and methods of use
|
TWI812739B
(zh)
|
2018-06-21 |
2023-08-21 |
景凱生物科技股份有限公司 |
Nadph氧化酶抑制劑、含其的醫藥組合物、及其應用
|
KR20210019119A
(ko)
|
2018-07-09 |
2021-02-19 |
리버 인스티튜트, 아이엔씨 |
Nav1.8을 억제하기 위한 피리다진(PYRIDAZINE) 화합물
|
AU2019301628A1
(en)
|
2018-07-09 |
2021-01-28 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting NaV1.8
|
US20210347785A1
(en)
|
2018-08-01 |
2021-11-11 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
Preparation and application of aromatic compound having immunoregulatory function
|
WO2020033413A2
(en)
|
2018-08-07 |
2020-02-13 |
Tosk, Inc. |
Modulators of ras gtpase
|
WO2020034062A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
Process for the reductive amination of a carbonyl compound
|
WO2020034058A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
PROCESS FOR REDUCTIVE AMINATION OF α,β-UNSATURATED CARBONYL COMPOUND
|
WO2020051207A2
(en)
|
2018-09-04 |
2020-03-12 |
Magenta Therapeutics Inc. |
Aryl hydrocarbon receptor antagonists and methods of use
|
MX2021003559A
(es)
|
2018-09-28 |
2021-08-24 |
Acucela Inc |
Inhibidores de vap-1.
|
KR102092838B1
(ko)
|
2018-10-02 |
2020-03-24 |
성균관대학교산학협력단 |
신규 퓨란계 폴리카보네이트 및 이의 제조 방법
|
WO2020072835A1
(en)
|
2018-10-03 |
2020-04-09 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
TW202028183A
(zh)
|
2018-10-10 |
2020-08-01 |
大陸商江蘇豪森藥業集團有限公司 |
含氮雜芳類衍生物調節劑、其製備方法和應用
|
EP3866798A4
(en)
|
2018-10-15 |
2022-07-13 |
Dana-Farber Cancer Institute, Inc. |
ENHANCED TRANSCRIPTIONAL ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND THEIR USES
|
US11377438B2
(en)
|
2018-11-02 |
2022-07-05 |
Merck Sharp & Dohme Llc |
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors
|
WO2020092187A1
(en)
|
2018-11-02 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
2-amino-n-phenyl-nicotinamides as nav1.8 inhibitors
|
KR102151855B1
(ko)
|
2018-11-30 |
2020-09-03 |
롯데케미칼 주식회사 |
공액 디엔계 및 방향족 비닐계 공중합체의 제조 방법 및 이로부터 제조된 공액 디엔계 및 방향족 비닐계의 공중합체를 포함하는 타이어
|
EP3891157A4
(en)
|
2018-12-05 |
2022-08-31 |
Merck Sharp & Dohme Corp. |
4-AMINO- OR 4-ALKOXY-SUBSTITUTED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATE SODIUM CHANNELS
|
WO2020118036A1
(en)
|
2018-12-06 |
2020-06-11 |
The Children's Medical Center Corporation |
Antibacterial compounds and uses thereof
|
EP3894392A4
(en)
|
2018-12-11 |
2022-08-24 |
Duke University |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
JP2022515909A
(ja)
|
2019-01-04 |
2022-02-22 |
ジエンス ヘンルイ メデイシンカンパニー リミテッド |
6-オキソ-1,6-ジヒドロピリダジン誘導体、その製造方法およびその医用
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
CN113302262A
(zh)
|
2019-01-22 |
2021-08-24 |
默克专利股份有限公司 |
液晶聚合物膜的制备方法
|
WO2020151728A1
(zh)
|
2019-01-25 |
2020-07-30 |
江苏恒瑞医药股份有限公司 |
2-氧代-1,2-二氢吡啶类衍生物、其制备方法及其在医药上的应用
|
AU2019427489A1
(en)
|
2019-01-28 |
2021-07-22 |
Mitochondria Emotion, Inc. |
Mitofusin activators and methods of use thereof
|
WO2020160225A1
(en)
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
US20220160705A1
(en)
|
2019-03-20 |
2022-05-26 |
Cornell University |
Methods for controlling prostaglandin-mediated biological processes
|
WO2020191501A1
(en)
|
2019-03-27 |
2020-10-01 |
Algernon Pharmaceuticals Inc. |
Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
|
CN113785032A
(zh)
|
2019-04-30 |
2021-12-10 |
默克专利股份有限公司 |
反应性介晶
|
WO2020228922A1
(de)
|
2019-05-10 |
2020-11-19 |
Wacker Chemie Ag |
Kationische germanium(ii)-verbindungen, verfahren zu deren herstellung und deren verwendung als katalysator in der hydrosilylierung
|
CN114008025A
(zh)
|
2019-05-14 |
2022-02-01 |
美特波米德有限公司 |
Acss2抑制剂和其使用方法
|
US20220324880A1
(en)
|
2019-06-10 |
2022-10-13 |
Kymara Therapeutics, Inc. |
Smarca inhibitors and uses thereof
|
WO2020254493A1
(en)
|
2019-06-21 |
2020-12-24 |
Bayer Aktiengesellschaft |
Thienylhydroxyisoxazolines and derivatives thereof
|
CN114040911A
(zh)
|
2019-06-27 |
2022-02-11 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为nav1.8抑制剂的2,3-二氢喹唑啉化合物
|
WO2021001739A1
(en)
|
2019-07-02 |
2021-01-07 |
Effector Therapeutics, Inc. |
Translational enhancers and related methods
|
CN112300069A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药(上海)有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
CN112300051A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药(上海)有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
WO2021032074A1
(zh)
|
2019-08-19 |
2021-02-25 |
江苏恒瑞医药股份有限公司 |
苯甲酰胺稠芳环类衍生物、其制备方法及其在医药上的应用
|
CN112390745B
(zh)
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
CN112441969A
(zh)
|
2019-08-30 |
2021-03-05 |
明慧医药(上海)有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
CN113906013B
(zh)
|
2019-09-12 |
2024-03-12 |
上海济煜医药科技有限公司 |
吡啶氮氧化合物及其制备方法和用途
|
CA3150673A1
(en)
|
2019-10-17 |
2021-04-22 |
Enyo Pharma |
THIOPHENE DERIVATIVES FOR USE IN THE TREATMENT OF PORTAL INFLAMMATION AND FIBROSIS
|
BR112022010924A2
(pt)
|
2019-12-06 |
2022-09-06 |
Vertex Pharma |
Tetra-hidrofuranos substituídos como moduladores de canais de sódio
|
CN111217776A
(zh)
|
2020-01-19 |
2020-06-02 |
中国人民解放军军事科学院军事医学研究院 |
含苯并杂环结构的酰胺衍生物、组合物和应用
|
WO2021239117A1
(en)
|
2020-05-28 |
2021-12-02 |
Cullgen (Shanghai) , Inc. |
Modified proteins and protein degraders
|
MX2022015857A
(es)
|
2020-06-10 |
2023-01-24 |
Amgen Inc |
Compuestos de dihidroquinolin sulfonamida de heteroalquilo.
|
JP2021195367A
(ja)
|
2020-06-10 |
2021-12-27 |
アムジエン・インコーポレーテツド |
シクロプロピルジヒドロキノリンスルホンアミド化合物
|
JP2021195368A
(ja)
|
2020-06-10 |
2021-12-27 |
アムジエン・インコーポレーテツド |
シクロブチルジヒドロキノリンスルホンアミド化合物
|
KR20230026404A
(ko)
|
2020-06-17 |
2023-02-24 |
머크 샤프 앤드 돔 엘엘씨 |
Nav1.8 억제제로서의 2-옥소-옥사졸리딘-5-카르복스아미드
|
IL299180A
(en)
|
2020-06-17 |
2023-02-01 |
Merck Sharp & Dohme Llc |
2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
|
KR20230026405A
(ko)
|
2020-06-17 |
2023-02-24 |
머크 샤프 앤드 돔 엘엘씨 |
Nav1.8 억제제로서의 5-옥소피롤리딘-3-카르복스아미드
|
GB202011996D0
(en)
|
2020-07-31 |
2020-09-16 |
Adorx Therapeutics Ltd |
Antagonist compounds
|
IL300626A
(en)
|
2020-08-14 |
2023-04-01 |
Siteone Therapeutics Inc |
Ketone-free inhibitors of NAV1.7 for the treatment of pain
|
TW202214259A
(zh)
|
2020-08-19 |
2022-04-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
一種選擇性NaV抑制劑的前藥及其晶型
|
WO2022037647A1
(zh)
|
2020-08-19 |
2022-02-24 |
江苏恒瑞医药股份有限公司 |
一种选择性Nav抑制剂的结晶形式及其制备方法
|
CN111808019B
(zh)
|
2020-09-08 |
2020-11-27 |
上海济煜医药科技有限公司 |
一种并环化合物及其应用
|
EP4217442A1
(en)
|
2020-09-24 |
2023-08-02 |
Merck Patent GmbH |
Polymerizable liquid crystal material and polymerized liquid crystal film
|
WO2022070048A1
(en)
|
2020-09-29 |
2022-04-07 |
Cadila Healthcare Limited |
Novel amide derivatives
|
WO2022086986A1
(en)
|
2020-10-21 |
2022-04-28 |
Kura Oncology, Inc. |
Treatment of hematological malignancies with inhibitors of menin
|
CN112225695B
(zh)
|
2020-12-15 |
2021-03-02 |
上海济煜医药科技有限公司 |
一种氮氧化合物及其制备方法和用途
|
CN112457294B
(zh)
|
2021-01-27 |
2021-06-04 |
上海济煜医药科技有限公司 |
一种作为NaV1.8阻滞剂的化合物及其制备方法和用途
|